ENVISIONONE Trademark

Trademark Overview


On Saturday, March 30, 2024, a trademark application was filed for ENVISIONONE with the United States Patent and Trademark Office. The USPTO has given the ENVISIONONE trademark a serial number of 98476408. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, January 14, 2025. This trademark is owned by Envision Pharma Inc.. The ENVISIONONE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Web site hosting services for the life science, pharmaceutical and bio-pharmaceutical industries, and academic research organisations; Software as a service (SAAS) services, namely, hosting software for use by others for improving the efficiency in which companies bring products to market in the life science, pharmaceutical and bio-pharmaceutical industries, and academic research organisations; Rental of software for improving the efficiency in which companies bring products to market in the life science, pharmaceutical and bio-pharmaceutical industries, and academic research organisations; Platform as a service (PAAS) featuring computer software platforms for improving the efficiency in which companies bring products to market in the life science, pharmaceutical and bio-pharmaceutical industries, and academic research organisations; Design, development and implementation of software and software platforms for the life science, pharmaceutical and bio-pharmaceutical industries and acade...
envisionone

General Information


Serial Number98476408
Word MarkENVISIONONE
Filing DateSaturday, March 30, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, January 14, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 14, 2025

Trademark Statements


Pseudo MarkENVISION ONE
Goods and ServicesWeb site hosting services for the life science, pharmaceutical and bio-pharmaceutical industries, and academic research organisations; Software as a service (SAAS) services, namely, hosting software for use by others for improving the efficiency in which companies bring products to market in the life science, pharmaceutical and bio-pharmaceutical industries, and academic research organisations; Rental of software for improving the efficiency in which companies bring products to market in the life science, pharmaceutical and bio-pharmaceutical industries, and academic research organisations; Platform as a service (PAAS) featuring computer software platforms for improving the efficiency in which companies bring products to market in the life science, pharmaceutical and bio-pharmaceutical industries, and academic research organisations; Design, development and implementation of software and software platforms for the life science, pharmaceutical and bio-pharmaceutical industries and academic research organisations; Software development for others in the life science, pharmaceutical and bio-pharmaceutical industries, and academic research organisations in the field of software configuration management; Providing a web hosting platform for the life science, pharmaceutical and biopharmaceutical industries and academic research organisations; Installation, maintenance, repair and updating of computer software and computer software platforms for the life science, pharmaceutical and bio-pharmaceutical industries and academic research organisations; Design, development and implementation of software for disclosing and disseminating scientific and medical data and information, managing evidence and tracking of scientific activity and grant requests; Software as a service (SAAS) services, namely, hosting software for global use by others for disclosing and disseminating scientific and medical data and information, managing evidence and tracking of scientific activity and grant requests; Software development for others in the field of software configuration management for disclosing and disseminating scientific and medical data and information, managing evidence and tracking of scientific activity and grant requests; Design, development and implementation of software platforms that incorporate integrated and configurable software modules for disclosing and disseminating scientific and medical data and information, managing evidence and tracking of scientific activity and grant requests; Platform as a service (PAAS) featuring computer software platforms incorporating integrated and configurable software modules for disclosing and disseminating scientific and medical data and information, managing evidence and tracking of scientific activity and grant requests; Software development for others in the field of software platform configuration management for disclosing and disseminating scientific and medical data and information, managing evidence and tracking of scientific activity and grant requests; Technical support services, namely, technical advice related to the repair of computer software; Technical support services, namely, technical advice related to the maintenance of computer software; Consultancy services relating to software as a service (SAAS) services and the selection of software applications; Advisory, consultancy and information services relating to all the aforesaid services

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, March 30, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEnvision Pharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFairfield, CT 06824

Party NameEnvision Pharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFairfield, CT 06824

Trademark Events


Event DateEvent Description
Saturday, March 30, 2024NEW APPLICATION ENTERED
Monday, September 2, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 10, 2024ASSIGNED TO EXAMINER
Wednesday, November 20, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 20, 2024NON-FINAL ACTION WRITTEN
Wednesday, November 20, 2024NON-FINAL ACTION E-MAILED
Wednesday, December 18, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 18, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 18, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 18, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 8, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 14, 2025PUBLISHED FOR OPPOSITION
Tuesday, January 14, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED